Introduction {#section1-1076029620930272}
============

Deep vein thrombosis (DVT) of the lower extremities is a common complication in trauma patients. The incidence of DVT after trauma was reported to be approximately 9.1% to 11.1%.^[@bibr1-1076029620930272],[@bibr2-1076029620930272]^ Deep vein thrombosis should be prevented and treated in a timely manner; otherwise, it can lead to chronic pain, secondary varicose veins, or ulcers, which seriously affect patients' quality of life. Fatal pulmonary embolism can also occur in some cases.^[@bibr3-1076029620930272]^ In recent years, orthopedists have paid increasing attention to the prophylaxis and treatment of DVT.

Currently, pharmacological prevention is considered among the most effective methods to decrease the incidence of lower extremity DVT.^[@bibr4-1076029620930272]^ Traditional low-molecular-weight heparin (LMWH)^[@bibr5-1076029620930272][@bibr6-1076029620930272]--[@bibr7-1076029620930272]^ is a popular choice. However, it can lead to local pain and even subcutaneous induration, while some patients develop heparin-induced thrombocytopenia that leads to bleeding and other adverse events. New oral anticoagulants (selective factor Xa inhibitors such as rivaroxaban^[@bibr8-1076029620930272]^ and apixaban^[@bibr9-1076029620930272]^) have made postoperative anticoagulant therapy more convenient and provided a sustained treatment strategy for venous thrombosis.^[@bibr10-1076029620930272]^

For patients with high risk of thrombosis, perioperative prevention is needed in addition to continued anticoagulant therapy after discharge to prevent fatal pulmonary embolism caused by DVT. In our hospital, LMWH was used during hospitalization, and rivaroxaban was used after discharge.

In one study with \>2000 patients from a Chinese population,^[@bibr8-1076029620930272]^ patients were given rivaroxaban or LMWH to prevent DVT at admission and while awaiting for surgery and then shortly after surgery. However, lower extremity vascular ultrasonography or angiography to screen for new DVT was only performed when lower limb swelling, local tenderness, or unexplained fever occurred. As most cases of lower extremity DVT could change during the operation,^[@bibr11-1076029620930272]^ noninvasive vascular ultrasonography should be used as a routine examination modality, especially at different time points in the perioperative period. In this study, the objective was to investigate the different onset times and perioperative changes of DVT in patients with lower extremity fractures who received LMWH and rivaroxaban therapy.

Methods {#section2-1076029620930272}
=======

Ethics Statement {#section3-1076029620930272}
----------------

This study analyzed the data of patients with lower extremity fractures who were admitted between June 1, 2016, and March 31, 2017, in Honghui Hospital, Xi'an Jiaotong University. The study was approved by the ethics review board of Xi'an Jiaotong University.

Inclusion and Exclusion Criteria {#section4-1076029620930272}
--------------------------------

The inclusion criteria were as follows: (a) age of ≥16 years; (b) acute fractures that require surgical treatment, including pelvic, femoral, tibial, fibular, ankle, and foot injuries; and (c) preoperative, postoperative, and 1-month postoperative ultrasonographic results are available.

The exclusion criteria were as follows: fractures with delayed treatment (\>3 weeks from injury to surgery), open soft tissue fractures, serious medical problems that make the patient unsuitable for surgery, and poor treatment compliance. We excluded delayed fractures because of the long interval between the fracture onset and operation, and the complex surgical procedure required. In addition, patients with anticoagulation contraindications (at high risk of stroke or bleeding) were excluded from the study.

Treatment {#section5-1076029620930272}
---------

All the patients who were admitted to the hospital were routinely assessed using the Risk Assessment Profile for Thromboembolism score for thromboembolism risk.^[@bibr12-1076029620930272]^ At the same time, we also assessed whether the patients had anticoagulation contraindications. For patients without anticoagulation contraindications, LMWH (3800 IU/0.4 mL once per day, Fraxiparine; Glaxo Wellcome Production, GlaxoSmithKline) was subcutaneously injected to prevent DVT. Then, Doppler ultrasonography was performed to screen for DVT. The patients with DVT received subcutaneous injections of LMWH (3800 IU/0.4 mL, twice per day). The therapeutic anticoagulation protocol was guided with hospital consultation from the department of vascular surgery. When the results of the preoperative ultrasonography performed by the department of vascular surgery showed central or mixed thrombosis, an inferior vena cava filter was used to prevent fatal pulmonary embolism if needed. The anticoagulant therapy was discontinued 12 hours before surgery and resumed 24 hours after surgery. When the patient was discharged, the protocol was changed to rivaroxaban therapy (10 or 20 mg once daily, Xarelto; Bayer HealthCare AG) until 35 days after operation.^[@bibr13-1076029620930272]^

In addition, mechanical thromboprophylaxis (foot intermittent pneumatic compression sleeve, 20 minutes twice a day) was used. Blood samples were collected on admission (2 hours after admission), 1 day before operation, and 1 and 5 days after operation, and 30 days after operation. The aim testing indexes included [d]{.smallcaps}-dimer level and routine blood tests. The timing points were identified to evaluate the patients' general conditions and coagulation states at admission, preoperation, postoperation, and before discharge.^[@bibr13-1076029620930272]^

We used Doppler ultrasonography to diagnose DVT. The diagnostic criterion for fresh thrombosis was the presence of a constant intraluminal filling defect.^[@bibr14-1076029620930272]^ The patients were examined before, after operation, and 1 month after surgery. All the patients underwent ultrasonography in both lower limbs 1 day before the planned surgery and on the third to the fifth day after operation, and 1 month after surgery. The DVT cases were classified into 3 types as follows: central (femoral and iliac veins), peripheral (calf muscle, fibular, and anterior/posterior tibial veins), and mixed thrombosis (both central and peripheral thromboses).^[@bibr13-1076029620930272]^ According to their ultrasonography results, the patients were divided into 2 groups: a thrombosis group and a non-thrombosis group.

Statistics Analyses {#section6-1076029620930272}
-------------------

Statistical analysis was performed using SPSS Version 19.0 (SPSS Inc.). The incidence was reported as a percentage. An independent-sample *t* test and a χ^2^ test were used for the statistical analyses. If the *P* value of a factor was \<.1 in the univariate analysis, then the variable was selected for multivariate analysis. A multivariate analysis was used to detect the risk or protective factors. The difference was considered to indicate statistical significance if the *P* value was less than .05.

Results {#section7-1076029620930272}
=======

Patient Demographic and Clinical Characteristics {#section8-1076029620930272}
------------------------------------------------

A total of 404 patients who met the inclusion criteria were included in the study, between June 1, 2016, and March 31, 2017. Of the patients, 208 were female and 196 were male, aged 18 to 88 years. In total, 193 patients had left lower extremity fractures; 185, right lower extremity fractures; 5, bilateral lower extremity fractures; and 21, pelvic and acetabular fractures. Of 263 knee proximal fractures, 69 were around the knee and 72 were distal to the knee. Combined multiple injuries were diagnosed in 50 patients. The number of patients with specific comorbidities was as follows: 68, primary hypertension; 60, coronary heart disease; 32, diabetes; and 14, cerebral stroke. None of the patients developed pulmonary embolism in the hospital.

Incidence of DVT on Preoperative Ultrasonography {#section9-1076029620930272}
------------------------------------------------

In the preoperative ultrasonography result, 143 patients had thrombosis (35%; [Table 1](#table1-1076029620930272){ref-type="table"}). Of all the DVT cases, 31% were peripheral; 1%, central; and 3%, mixed. Peripheral DVT constituted 88% (126/143) of all the DVT cases. Symptomatic DVT was found in 24 patients (17%).

###### 

Patient Characteristics According to Preoperative Ultrasound.^a^

![](10.1177_1076029620930272-table1)

                                                      Thrombosis       No thrombosis    Overall          *P*
  --------------------------------------------------- ---------------- ---------------- ---------------- ------
  Number                                              143              261              404              
  Age                                                 64.83 ± 15.94    55.15 ± 19.77    58.57 ± 19.06    .000
  Sex                                                                                                    
   Female                                             84               124              208              .031
   Male                                               59               137              196              
  Unilateral or bilateral fracture                                                                       
   Left lower limb                                    72               121              193              .135
   Right lower limb                                   67               118              185              
   Both lower limbs                                   0                5                5                
   Pelvis                                             4                17               21               
  Types of fracture                                                                                      
   Hip fractures                                      97               166              263              .051
   Knee fractures                                     29               40               69               
   Ankle fractures                                    17               55               72               
  Medical morbidity                                                                                      
   Hypertension (%)                                   27 (18.88)       41 (15.71)       68               .415
   Diabetes (%)                                       17 (11.89)       15 (5.75)        32               .029
   Coronary heart disease (%)                         26 (18.18)       34 (13.03)       60               .164
   Stroke (%)                                         5 (3.50)         9 (3.45)         14               .980
   Associated trauma (%)                              19 (13.29)       31 (11.88)       50               .681
   BMI                                                22.53 ± 3.91     22.96 ± 4.41     22.82 ± 4.24     .595
   Days between fracture and hospitalization (days)   1.71 ± 3.11      1.36 ± 3.85      1.48 ± 3.61      .357
   Days between fracture and operation (days)         6.32 ± 3.47      6.27 ± 4.81      6.29 ± 4.38      .913
  ASA classification                                                                                     
   1                                                  17               60               77               .020
   2                                                  94               156              250              
   3                                                  32               45               77               
  Serum markers                                                                                          
   HGB at admission (g/L)                             117.47 ± 18.19   124.82 ± 18.76   122.21 ± 18.87   .000
   HCT at admission (%)                               35.28 ± 5.44     37.27 ± 5.25     36.57 ± 5.39     .000
   HGB at preoperation (g/L)                          111.05 ± 16.52   121.33 ± 17.97   117.57 ± 18.11   .000
   HCT at preoperation (%)                            33.38 ± 4.81     35.99 ± 5.96     35.04 ± 5.70     .001
   [d]{.smallcaps}-dimer at admission (mg/L)          11.93 ± 11.82    11.74 ± 14.86    11.81 ± 13.84    .892
  [ d]{.smallcaps}-dimer at preoperation (mg/L)       6.06 ± 5.10      4.11 ± 4.71      4.86 ± 4.97      .008
   CRP at admission (mg/L)                            20.57 ± 30.05    21.59 ± 32.32    21.23 ± 31.47    .829

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C-reactive protein; HGB, hemoglobin; HCT, Hematocrit.

^a^ Coronary heart disease includes chronic myocardial ischemia, ST segment changes without clinical symptoms, and delayed myocardial infarction in electrocardiograms. Stroke includes fresh and delayed cerebral ischemia and hemorrhage in computed tomography or magnetic resonance imaging.

Of the 26 patients with bilateral limb or pelvic fractures, 4 (15%) had evidence of DVT. Among the remaining 378 cases, DVT occurred in 139 (37%). Of the 139 patients, 93 had DVT in the injured ipsilateral lower extremity, 20 had DVT in the uninjured contralateral lower extremity, and 26 had DVT in both lower extremities. The incidence of DVT on the uninjured side was 12% (46/378), accounting for 33% (46/139) of all the preoperative DVT cases. The multivariate analysis revealed that age (odds ratio \[OR\]: 1.03; 95% CI: 1.01-1.04; *P* = .000) was an independent risk factor for preoperative DVT ([Table 2](#table2-1076029620930272){ref-type="table"}).

###### 

Multivariate Analysis of Preoperative, Postoperative, and 1-Month Postoperative DVT.

![](10.1177_1076029620930272-table2)

                                                                95% CI for OR   
  ----------------------- ------- ------ ------- ------ ------- --------------- -------
  Preoperation                                                                  
   Age                    0.03    0.01   22.83   .000   1.03    1.01            1.04
   Constant               −2.32   0.39   36.43   .000   0.10                    
  Postoperation                                                                 
   Age                    0.04    0.01   33.58   .000   1.04    1.03            1.05
    ASA-1                                6.91    .032                           
    ASA-2                 0.36    0.41   0.76    .384   1.43    0.64            3.18
    ASA-3                 0.74    0.30   5.94    .014   2.07    1.16            3.72
    Blood loss            0.00    0.00   5.57    .018   1.001   1.000           1.002
    Constant              −2.99   0.59   25.35   .000   0.05                    
  Postoperation 1 month                                                         
   Age                    0.04    0.01   47.03   .000   1.05    1.03            1.07
   Constant               −3.05   0.41   55.20   .000   0.05                    

Abbreviations: ASA, American Society of Anesthesiologists; DVT, deep vein thrombosis; OR, odds ratio; SE, standard error.

Incidence of DVT on Postoperative Ultrasonography {#section10-1076029620930272}
-------------------------------------------------

In the postoperative ultrasonography result, thrombosis was found in 223 patients (55%; [Table 3](#table3-1076029620930272){ref-type="table"}). Of all the DVT cases, 49% were peripheral; 1%, central; and 5%, mixed. Peripheral DVT constituted 88% (196/223) of all the DVT cases. Symptomatic DVT was found in 56 patients (25%).

###### 

Patient Characteristics According to Postoperative Ultrasound.

![](10.1177_1076029620930272-table3)

                                                          Thrombosis         No Thrombosis      Overall            *P*
  ------------------------------------------------------- ------------------ ------------------ ------------------ ------
  Number                                                  223                181                404                
  Age                                                     64.06 ± 15.80      51.81 ± 20.54      58.57 ± 19.06      .000
  Sex                                                                                                              
   Female                                                 125                83                 208                .041
   Male                                                   98                 98                 196                
  Unilateral or bilateral fracture                                                                                 
   Left lower limb                                        107                86                 193                .906
   Right lower limb                                       103                82                 185                
   Both lower limbs                                       3                  2                  5                  
   Pelvis                                                 10                 11                 21                 
  Types of fracture                                                                                                
   Hip fractures                                          158                105                263                .000
   Knee fractures                                         41                 28                 69                 
   Ankle fractures                                        24                 48                 72                 
  Medical morbidity                                                                                                
   Hypertension (%)                                       48 (21.52)         20 (11.05)         68                 .005
   Diabetes (%)                                           23 (10.31)         9 (4.97)           32                 .048
   Coronary heart disease (%)                             41 (18.38)         19 (10.50)         60                 .027
   Stroke (%)                                             9 (4.030)          5 (2.76)           14                 .486
   Associated trauma (%)                                  25 (11.21)         25 (13.81)         50                 .430
   BMI                                                    22.74 ± 3.84       22.89 ± 4.63       22.82 ± 4.24       .837
   Days between fracture and hospitalization (days)       1.47 ± 3.27        1.50 ± 4.00        1.48 ± 3.61        .920
   Days between fracture and operation (days)             6.04 ± 3.64        6.59 ± 5.14        6.29 ± 4.38        .229
   Length of hospital (days)                              10.09 ± 3.10       10.28 ± 4.03       10.18 ± 3.54       .597
  Surgical procedures                                                                                              
   ORIF                                                   167                153                320                .014
   Hemiarthroplasty                                       40                 24                 64                 
   THR                                                    15                 2                  17                 
   EF                                                     1                  2                  3                  
  Duration of operation (min)                             120.25 ± 68.98     127.18 ± 72.61     123.35 ± 70.62     .327
  Transfusion (U)                                         1.15 ± 1.49        0.90 ± 1.51        1.03 ± 1.48        .088
  Blood loss (mL)                                         338.86 ± 342.83    278.34 ± 317.31    311.61 ± 332.53    .077
  Liquid transfusion (mL)                                 1789.19 ± 528.12   1899.62 ± 732.63   1838.91 ± 630.06   .080
  Drainage (mL)                                           196.74 ± 104.12    179.18 ± 86.73     186.89 ± 94.65     .365
  ASA classification                                                                                               
   1                                                      29                 48                 77                 .002
   2                                                      150                100                250                
   3                                                      44                 33                 77                 
  Serum markers                                                                                                    
   HGB at admission (g/L)                                 119.85 ± 17.56     125.08 ± 20.03     122.21 ± 18.87     .006
   HCT at admission (%)                                   36.06 ± 5.27       37.18 ± 5.29       36.57 ± 5.39       .039
   HGB at preoperation (g/L)                              114.00 ± 16.33     122.63 ± 19.34     117.57 ± 18.11     .000
   HCT at preoperation (%)                                34.24 ± 5.03       36.16 ± 6.39       35.04 ± 5.70       .012
   HGB at postoperative 1 day (g/L)                       107.50 ± 13.45     110.83 ± 16.74     108.99 ± 15.08     .032
   HCT at postoperative 1 day (%)                         31.83 ± 4.44       32.81 ± 4.74       32.27 ± 4.60       .035
   HGB at postoperative 5 days (g/L)                      102.90 ± 13.62     105.82 ± 19.91     104.10 ± 16.49     .319
   HCT at postoperative 5 days (%)                        30.83 ± 3.92       31.10 ± 5.73       30.94 ± 4.73       .746
  [ d]{.smallcaps}-dimer at admission (mg/L)              13.15 ± 13.64      10.13 ± 13.94      11.81 ± 13.84      .032
   [d]{.smallcaps}-dimer at preoperation (mg/L)           5.45 ± 4.88        4.01 ± 4.98        4.86 ± 4.97        .048
  [ d]{.smallcaps}-dimer at postoperative 1 day (mg/L)    10.01 ± 10.97      4.46 ± 3.93        7.56 ± 9.02        .000
   [d]{.smallcaps}-dimer at postoperative 5 days (mg/L)   8.92 ± 7.05        5.21 ± 2.85        7.31 ± 5.90        .000

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C-reactive protein; EF, external fixation ORIF, open reduction internal fixation; THR, total hip replacement; HGB, hemoglobin; HCT, Hematocrit.

Of the 26 patients with bilateral limb or pelvic fractures, 13 (50%) had evidence of DVT. Among the remaining 378 cases, DVT occurred in 210 (55%). Of the 210 patients, 128 had DVT in the injured ipsilateral lower extremity, 18 had DVT in the uninjured contralateral lower extremity, and 64 had DVT in both lower extremities. The incidence of DVT on the uninjured side was 22% (82/378), accounting for 39% (82/210) of all postoperative DVT cases. The results of the multivariate analysis showed that age (OR: 1.04; 95% CI: 1.03-1.05; *P* = .000), blood loss (OR: 1.001; 95% CI: 1.000-1.002; *P* = .018), and ASA classification (OR: 2.07; 95% CI: 1.16-3.72; *P* = .014) were independent risk factors for postoperative DVT ([Table 2](#table2-1076029620930272){ref-type="table"}).

Incidence of DVT on 1-Month Postoperative Ultrasonography {#section11-1076029620930272}
---------------------------------------------------------

The postoperative ultrasonography result showed that 161 patients had thrombosis (40%; [Table 4](#table4-1076029620930272){ref-type="table"}). Of all the DVT cases, 36% were peripheral; 1%, central; and 3%, mixed. Peripheral DVT constituted 91% (146/161) of all DVT cases. Symptomatic DVT was found in 10 patients (6%).

###### 

Patient Characteristics According to 1-Month Postoperative Ultrasound.

![](10.1177_1076029620930272-table4)

                                                           Thrombosis         No thrombosis      Overall            *P*
  -------------------------------------------------------- ------------------ ------------------ ------------------ ------
  Number                                                   161                243                404                
  Age                                                      67.01 ± 14.72      52.98 ± 19.67      58.57 ± 19.06      .000
  Sex                                                                                                               
   Female                                                  96                 112                208                .008
   Male                                                    65                 131                196                
  Unilateral or bilateral fracture                                                                                  
   Left lower limb                                         80                 113                193                .345
   Right lower limb                                        75                 110                185                
   Both lower limbs                                        1                  4                  5                  
   Pelvis                                                  5                  16                 21                 
  Types of fracture                                                                                                 
   Hip fractures                                           117                146                263                .003
   Knee fractures                                          28                 41                 69                 
   Ankle fractures                                         16                 56                 72                 
  Medical morbidity                                                                                                 
   Hypertension (%)                                        39 (24.22)         29 (11.93)         68                 .001
   Diabetes (%)                                            18 (11.18)         14 (5.76)          32                 .048
   Coronary heart disease (%)                              33 (20.50)         27 (11.11)         60                 .009
   Stroke (%)                                              6 (3.73)           8 (3.29)           14                 .815
   Associated trauma (%)                                   16 (9.94)          34 (13.99)         50                 .226
   BMI                                                     21.97 ± 3.32       23.29 ± 4.63       22.82 ±4 .24       .093
   Length of hospital (days)                               9.83 ± 3.34        10.41 ± 3.66       10.18 ± 3.54       .104
  Surgical procedures                                                                                               
   ORIF                                                    117                203                320                .054
   Hemiarthroplasty                                        32                 32                 64                 
   THR                                                     10                 7                  17                 
   EF                                                      2                  1                  3                  
  Duration of operation (min)                              115.52 ± 63.81     128.54 ± 74.47     123.35 ± 70.62     .070
  Transfusion (U)                                          1.17 ± 1.42        0.95 ± 1.52        1.03 ± 1.48        .144
  Blood loss (ml)                                          329.54 ± 360.54    299.76 ± 312.89    311.61 ± 332.53    .392
  Liquid transfusion (ml)                                  1758.81 ± 560.52   1891.86 ± 667.96   1838.91 ± 630.06   .032
  Drainage(ml)                                             188.46 ± 111.89    185.85 ± 82.33     186.89 ± 94.65     .894
  ASA classification                                                                                                
   1                                                       19                 58                 77                 .008
   2                                                       106                144                250                
   3                                                       36                 41                 77                 
  Serum markers                                                                                                     
   HGB at postoperative 1 month (g/L)                      130.84 ± 16.50     136.64 ± 20.00     108.99 ± 15.08     .003
   HCT at postoperative 1 month (%)                        41.13 ± 4.44       43.50 ± 10.46      32.27 ± 4.60       .008
  [ d]{.smallcaps}-dimer at postoperative 1 month (mg/L)   2.57 ± 4.06        1.25 ± 1.68        7.31 ± 5.90        .000

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C-reactive protein; EF, external fixation; ORIF, open reduction internal fixation; THR, total hip replacement.

Of the 26 patients with bilateral limb or pelvic fractures, 6 (23%) had evidence of DVT. Among the remaining 378 cases, DVT occurred in 155 (41%). Of the 155 patients, 81 had DVT in the injured ipsilateral lower extremity, 26 had DVT in the uninjured contralateral lower extremity, and 48 had DVT in both lower extremities. The incidence of DVT on the uninjured side was 20% (74/378), accounting for 48% (74/155) of all 1-month postoperative DVT cases. The results of multivariate analysis showed that age (OR: 1.05; 95% CI: 1.03-1.07; *P* = .000) was an independent risk factor for 1-month postoperative DVT ([Table 2](#table2-1076029620930272){ref-type="table"}).

Perioperative Changes of DVT Before and After Operation {#section12-1076029620930272}
-------------------------------------------------------

The perioperative changes of DVT before, after, and 1 month after operation are shown in [Figure 1](#fig1-1076029620930272){ref-type="fig"}. Of all 404 patients, 66% showed no changes in DVT status from pre- to post-op ultrasonography (40.10% no DVT, 24.26% peripheral, 0.25% central, and 0.99% mixed DVT). Moreover, 5% (3.96% peripheral, 0.25% central, and 0.5% mixed DVT) of the patients who had preoperative DVT no longer had thrombosis postoperatively. In addition, 25% (22.03% peripheral, 0.74% central, and 1.73% mixed DVT) of the patients progressed from having no thrombosis preoperatively to having peripheral, central, or mixed DVT postoperatively.

![The incidence of preoperative deep vein thrombosis (DVT) (A), postoperative DVT (B), 1-month postoperative DVT (C), and the perioperative changes of DVT from pre-operation to post-operation (D), and from post-operation to 1-month post-operation (E).](10.1177_1076029620930272-fig1){#fig1-1076029620930272}

Of the 404 patients, 66% (37.62% no DVT, 26.98% peripheral, 0.50% central, and 1.24% mixed DVT) showed no changes after hospital discharge. Moreover, 23% (20.54% peripheral, 0.74% central, and 1.24% mixed DVT) of the patients who had postoperative DVT no longer had thrombosis postoperatively 1 month. In addition, 7% (6.19% peripheral and 0.99% mixed DVT) of the patients progressed from having no thrombosis postoperatively to having peripheral or mixed DVT 1-month postoperatively. From the postoperative to the 1-month follow-up ultrasound, there was a decrease in overall prevalence of DVT from 223 (55%) to 161 (40%).

Discussion {#section13-1076029620930272}
==========

We investigated the effects of LMWH administration followed by rivaroxaban therapy in the prevention of DVT in patients with lower extremity fractures. Our basic findings were as follows: (a) the incidence of perioperative DVT decreased over time. The incidence of postoperative DVT was 55% and that of 1-month postoperative DVT was 40%. (b) The incidence rates of preoperative, postoperative, and 1-month postoperative DVT on the uninjured side were 12%, 22%, and 20%, respectively. (c) The most variable DVT was peripheral DVT, which constituted 88%, 88%, and 91% of all preoperative, postoperative, and 1-month postoperative DVT cases, respectively. (d) Age was an independent risk factor for perioperative DVT.

Many factors contribute to the formation of thrombosis after trauma,^[@bibr15-1076029620930272],[@bibr16-1076029620930272]^ including age, sex, hypertension, diabetes, cerebral infarction, myocardial infarction, and so on. These are risk factors for thrombosis, especially in cases of fracture and surgery.^[@bibr17-1076029620930272],[@bibr18-1076029620930272]^ In this study, age showed a close relationship with thrombosis. Further, sex also plays an important role in thrombosis but is not an independent risk factor. Many studies have shown that females had high risk of DVT.^[@bibr13-1076029620930272],[@bibr14-1076029620930272]^ Increasing evidence suggests that women had higher platelet activity levels than men,^[@bibr19-1076029620930272][@bibr20-1076029620930272]--[@bibr21-1076029620930272]^ and estrogen likely plays a crucial role in the transcriptional regulation of coagulation protein genes.^[@bibr22-1076029620930272]^

This study is the first research on perioperative changes of DVT before, after, and 1 month after the surgery. In this study, we found that the incidence and severity of DVT were highest after the surgery. Compared with the preoperative incidence of DVT, the postoperative incidence of DVT tended to increase. The number of DVT cases increased by 89 new peripheral DVT cases, 7 new mixed DVT cases, and 3 new central DVT cases. Immobility due to severe pain after fracture and operation may cause venous stasis in the lower extremities, thus increasing the risk of DVT in these patients.^[@bibr23-1076029620930272]^ Twenty-nine new DVT cases (7%) occurred in the patients receiving rivaroxaban therapy, of which 25 were peripheral and 4 were mixed. We found 17 hip fractures, 3 patellar fractures, 5 tibial and fibular fractures, 2 pelvic and acetabular fractures, and 2 distal femoral fractures. Through a review, we found that most of these patients were elderly and confined in bed for a long time. This serves as a reminder of the importance of early weight bearing.

The incidence at 1 month after surgery showed a decreasing tendency as compared with that after operation. Selby et al reported a significant hypercoagulability within the first 24 hours after trauma, a state that was maintained for 5 to 14 days.^[@bibr24-1076029620930272]^ Meissner et al suggested that this hypercoagulation state persists for at least 1 month after injury in 80% of patients.^[@bibr25-1076029620930272]^ This may explain why 40% of patients had resisted DVT at 1 month after surgery despite the use of rivaroxaban for prophylaxis or therapy.

We also divided the patients according to fracture site. We found that the incidence of preoperative thrombosis was similar among the hip, knee, and ankle fractures. The incidence rates of DVT in hip and knee fractures were, respectively, 60% (158/263) and 59% (41/69) immediately after surgery, and 44% (117/263) and 41% (28/69) 1 month after surgery. The incidence rates of DVT were lower in the ankle fractures. Basques et al reported that the incidence of DVT in ankle factures was 0.8%,^[@bibr26-1076029620930272]^ and Pelet et al reported an incidence rate of 2.66%.^[@bibr27-1076029620930272]^ Shin et al reported an 11.1% incidence rate of hip preoperative DVT.^[@bibr1-1076029620930272]^ These findings suggest that fractures in the hip and knee are more prone to DVT than those in other regions of the lower extremity.

Peripheral DVT is the most variable form in the early stage and can occur in the calf muscle veins, fibular vein, and anterior/posterior tibial vein. Peripheral DVT occurred in 31% (126/404) of the patients before surgery, 49% (196/404) immediately after surgery, and 36% (146/404) at 1 month after surgery. Peripheral DVT accounted for 88%, 88%, and 91% of all preoperative, postoperative, and 1-month postoperative DVT cases, respectively. Palareti et al reported that the proportions of peripheral DVT cases ranged from 23.4% to 59.7%.^[@bibr28-1076029620930272]^ The calf muscle veins are among the most frequent areas for the development of DVT.^[@bibr29-1076029620930272]^ This is the reason why peripheral DVT is variable and changeable. Galanaud et al reported that the mortality rate is significantly lower in patients with isolated peripheral DVT than in those with proximal DVT.^[@bibr30-1076029620930272]^ Thus, peripheral DVT is relatively safer than proximal DVT, but peripheral DVT must be prevented from transitioning to proximal DVT or mixed DVT.

This study has some limitations. First, Doppler ultrasonography, which was used in the study, is not the gold standard method for the diagnosis of DVT. However, it is highly convenient and noninvasive as compared with radiography, and orthopedists have accepted ultrasonography as a diagnostic modality for DVT. Second, we did not specially analyze for symptomatic DVT because, in a recent study, asymptomatic DVT accounted for most overall DVT cases.^[@bibr28-1076029620930272]^ In this study, we investigated the perioperative changes of DVT and analyzed the overall incidence of DVT but not symptomatic DVT.

Conclusion {#section14-1076029620930272}
==========

In conclusion, the incidence of perioperative DVT decreased over time in the patients who received anticoagulation treatment. Age was an important risk factor for perioperative DVT.
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